Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire10 February 2026
Ascletis Selects Oral Amylin Receptor Peptide Agonist, ASC36, for Clinical Development
– Utilizing Ascletis’ Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8%…
Read More » -
Cision PR Newswire10 February 2026/C O R R E C T I O N — PremierOne Credit Union/
In the news release, PREMIERONE CREDIT UNION RECEIVES NATIONAL CERTIFICATION BY BANKING ADVOCATES AS SAFE, AFFORDABLE ACCOUNT, issued 09-Feb-2026 by…
Read More » -
Cision PR Newswire10 February 2026
In HelloNation, Electrical Expert Mister Sparky of Chattanooga Details When an Electrical Panel Upgrade Is Necessary
CHATTANOOGA, Tenn., Feb. 10, 2026 /PRNewswire/ — Why do some Chattanooga homes experience flickering lights or tripped breakers after adding…
Read More » -
Cision PR Newswire10 February 2026
Casino Jobs Stagnant Until 2034, OysterLink Finds
OysterLink analysis of U.S. Bureau of Labor Statistics data shows steady replacement hiring, shifting role demand and wide salary ranges…
Read More » -
Business Wire10 February 2026
Eclipse Signs Partnership Agreement With BNP Paribas to Power the Next Stage of Growth
The agreement includes a strategic equity investment in Eclipse by BNP Paribas PARIS–(BUSINESS WIRE)–Eclipse, a leading battery storage, development, and…
Read More » -
Business Wire10 February 2026
Vecima Declares Quarterly Dividend
VICTORIA, British Columbia–(BUSINESS WIRE)–Vecima Networks Inc. (TSX: VCM) today announces that, consistent with its previously announced dividend policy, the Board…
Read More » -
Business Wire10 February 2026
Pakistan Digital Authority and DFINITY Partner for Sovereign Cloud Infrastructure and AI Software Systems
Agreement establishes Pakistan Subnet of Internet Computer Platform (ICP), supports tamper‑proof digital infrastructure, enables local AI‑native software development and pilots…
Read More » -
Business Wire10 February 2026
Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China
Elecoglipron demonstrated a favorable safety and tolerability profile in Chinese adults living with obesity/overweight with or without type 2 diabetes…
Read More » -
Business Wire10 February 2026
Loomis Sayles Growth Equity Strategies Team Global Growth Strategy Reaches 10-Year Milestone
Two Decades of Growth Equity Investing, One Differentiated Approach Led by Aziz V. Hamzaogullari, CFA, Growth Equity Strategies Team Founder,…
Read More » -
Business Wire10 February 2026
PulteGroup Prices $800 Million Senior Notes Offering
ATLANTA–(BUSINESS WIRE)–PulteGroup, Inc. (NYSE: PHM) (“PulteGroup”) announced today the pricing of an underwritten public offering of $800 million in aggregate…
Read More »
